Spermosens are active in medical technology. The company specializes in the development of medical devices. The product portfolio is broad and includes products for male infertility and individually tailored fertility treatments. Research and development is conducted via its own technological platform that analyzes sperm quality, which is further used for medical data and potential fertilization. The largest operations are in the Nordic market.

Quotes for Spermosens AB (publ)

Right Now

+/-
0.4
%
3,54%
Latest
11.7
High
12
Low
11.3
Volume
47 259
Turnover (SEK)
549 597
Value (MSEK)
123,0

Board

CEO

  • John Lempert

Chairman Of The Board

  • Eva Nilsagård

Board

  • Ingela Liljeqvist Soltic
  • John Moll
  • Kushagr Punyani
  • Sören Melsing Frederiksen

Largest Owners

Name Capital % Votes % Date
Kushagr Punyani 16,61 16,61 2021-05-05
Sudha Srivastava 7,26 7,26 2021-05-05
Mohamad Takwa 4,07 4,07 2021-05-05
Johan Källstrand 3,63 3,63 2021-05-05
Bertil Lindkvist 3,16 3,16 2021-05-05
Emilie Hultin Takwa 3,16 3,16 2021-05-05
Polynom Investment AB 2,95 2,95 2021-05-05
Jens Erik Martin Olsson 2,44 2,44 2021-05-05
John Moll 2,43 2,43 2021-05-05
Jimmie Landerman 2,37 2,37 2021-05-05
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2021-08-19 Delårsrapport 2021-Q2

  • 2021-11-11 Delårsrapport 2021-Q3

  • 2022-02-10 Bokslutskommuniké 2021